Mitigating Racial Disparities in Shared Decision Making in the Intensive Care Unit

Sponsor
Duke University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05710744
Collaborator
National Institutes of Health (NIH) (NIH), National Heart, Lung, and Blood Institute (NHLBI) (NIH)
150
1
2
53
2.8

Study Details

Study Description

Brief Summary

This is a non randomized pilot trial aimed to:

Test the feasibility of an intervention to support intensive care unit clinicians in conducting shared decision making conversations with families of patients with acute respiratory failure. The goal of this intervention is to mitigate racial disparities in shared decision making.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Shared decision making tip sheet
N/A

Detailed Description

The care of critically ill patients with acute respiratory failure involves life-or-death decisions. Ideally, intensive care unit (ICU) clinicians should include patients or their families in shared decision making, which promotes goal-concordant care (i.e., care aligned with patients' preferences), reduces psychological distress for both families and clinicians, and shortens ICU length of stay. However, racial disparities have been documented in shared decision making and associated outcomes. In outpatient settings, clinicians treat Black patients differently from White patients, providing fewer treatment options, less prognostic information, and less emotional support, and making assumptions about rather than eliciting patient preferences. Disparities in shared decision making are likely to be amplified in the ICU because clinicians often do not have long-standing relationships with patients or families, and decisions are complex, emotional, and time-pressured. Yet, no interventions currently exist to address racial disparities in shared decision making about acute respiratory failure. This research will directly fill this gap.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Mitigating Racial Disparities in Shared Decision Making in the Intensive Care Unit
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2027
Anticipated Study Completion Date :
Dec 31, 2027

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Family Members of patients in the ICU

Family members will join routine meetings with the physicians treating with their critically ill loved ones.

Other: ICU Physicians

Physicians will view a tip sheet containing information about best practices of shared decision making with diverse individuals. Physicians will then conduct routine meetings with families of patients with acute respiratory failure.

Behavioral: Shared decision making tip sheet
Physicians will view tip sheets containing best practices for shared decision making with diverse families.

Outcome Measures

Primary Outcome Measures

  1. Intervention acceptability as measured by single Likert-scaled item completed by physicians [within 96 hours of signing study consent]

    Likert-scaled single item, ranging from 1 (not acceptable) to 5 (completely acceptable)

  2. Demand for the intervention measured by the proportion of physicians who viewed the intervention [within 96 hours of signing study consent]

    Percentage of physicians who viewed intervention by email "read" receipts, range 0 to 100%

  3. Fidelity to intervention measured by proportion of tip sheet phrases used by physicians [within 96 hours of signing study consent]

    Proportion of tip sheet phrases used in family meeting as determined by review of audio-recorded family meeting, range 0 to 100%

  4. Practicality as measured by proportion of screen eligible participants enrolled per month [through study completion, up to 1 year]

    Proportion screen eligible enrolled/month based on review of study logs, range 0 to 100%

  5. Practicality as measured by time to complete physician or family surveys [within 96 hours of signing study consent]

    Time to complete physician or family surveys as measured by review of study logs, range 0 to 60 minutes

  6. Practicality as measured by dropout rate from study [through study completion, up to 1 year]

    Dropout rate as ascertained by review of study logs, range 0 to 100%

Secondary Outcome Measures

  1. Decisional regret among families, measured by Decision Regret Scale [within 96 hours of signing study consent]

    Decision Regret Scale, range 5 (low regret) to 25 (high regret)

  2. Psychological distress among families, measured by Impact of Events Revised scale [within 96 hours of signing study consent]

    Impact of Events revised scale, range 0 (low stress) to 88 (extreme stress)

  3. Psychological distress among physicians, measured by moral distress scale [within 96 hours of signing study consent]

    Moral distress scale, range 0 (low distress) to 84 (extreme distress)

  4. Components of shared decision making, as measured by content analysis of family meeting recordings [through study completion, up to 1 year]

    A qualitative data analysis of transcripts from family-physician meetings using 14-item shared decision making framework from PMID 20642362, range 0 (poor shared decision making) to 14 (ideal shared decision making)

  5. Decisional conflict among families, measured by Decisional Conflict Scale [within 96 hours of signing study consent]

    Decisional Conflict Scale, range 0 (low conflict) to 64 (high conflict)

  6. ICU utilization among patients, as measured by length of stay [through study completion, up to 1 year]

    ICU length of stay ascertained from electronic medical record review

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Physician inclusion criterion:
  • ICU attending physician with at least 6 weeks of clinical service time in the 12 months preceding and following enrollment
Physician exclusion criterion:
  • Board certified in palliative care medicine
Patient inclusion criteria:
  • Admitted to the ICU

  • Being treated by a study physician currently and at least for the next 48 hours

  • ≥ 18 years of age upon admission to hospital

  • Mechanically ventilated ≥ 7 days continuously

Patient exclusion criterion:
  • Tracheostomy tube present or decision to pursue tracheostomy within next 7 days

  • Has decision making capacity as assessed by medical team

  • Extubation planned or death anticipated in next 24 hours

  • Patients who are prisoners or are pregnant

  • Awaiting organ transplantation during this hospitalization

  • Acute respiratory failure due to progression of chronic neuromuscular disease

  • No family decision maker available

Family member inclusion criteria:
  • Identified by medical team as person most involved in medical decision making for the patient

  • Confirmed to be patient's legally authorized representative

  • Self-identifies as non-Hispanic Black or White

  • ≥ 18 years of age at time of consent

  • Confirms conversational fluency in English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University Medical Center Durham North Carolina United States 27710

Sponsors and Collaborators

  • Duke University
  • National Institutes of Health (NIH)
  • National Heart, Lung, and Blood Institute (NHLBI)

Investigators

  • Principal Investigator: Deepshikha Ashana, M.D., Duke University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT05710744
Other Study ID Numbers:
  • Pro00111530
  • 1K23HL164968-01
First Posted:
Feb 2, 2023
Last Update Posted:
Feb 2, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Duke University

Study Results

No Results Posted as of Feb 2, 2023